A Case Report of a Patient With Intellectual Disability and Neurogenic Bladder Complicated With Sepsis

May 26, 2023 updated by: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
A case report of a patient with intellectual disability and neurogenic bladder complicated with sepsis

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

To summarize the individual care experience of a patient with neurogenic cystitis with sepsis and mental retardation. The main points of nursing care include: conducting personalized nuring care for early sepsis; carring out care for urinary incontinence and urinary tract infection; bulinding health-management plans with family members; and a full course of psychologic diversion that alleviates negative feelings among patients and family members.

Study Type

Observational

Enrollment (Actual)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Guangdong
      • Guangzhou, Guangdong, China, 510220
        • One Case of Individualized Nursing Plan for Sepsis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

A patient with neurogenic cystitis with sepsis and mental retardation.

Description

Inclusion Criteria:

Dysgnosia Neurogenic bladder Pyohemia

Exclusion Criteria:

Intellectually normal person No urinary infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lactic acid
Time Frame: During the first 6 days of ICU stay
"In some pathological conditions, such as respiratory failure or circulatory failure, tissue hypoxia may be induced, and due to this hypoxia, lactic acid in the body may be elevated." Elevated lactic acid in the body can cause lactic acidosis. Checking the blood lactate level may indicate the severity of the underlying disease.The normal range is 0.05mmol/L-1.7mmol/L.
During the first 6 days of ICU stay
Sequential Organ Failure Assessment
Time Frame: During the first 3 days of ICU stay
This scale can describe the dysfunction or failure of individual organs in a continuous form, and can evaluate the degree of mild dysfunction to severe failure. It can be used to measure the occurrence and development of single or whole organ dysfunction repeatedly in clinical research, so as to determine the characteristics describing organ dysfunction or failure, which has a closer relationship with sepsis.
During the first 3 days of ICU stay
Indicators of infection
Time Frame: During the first 6 days of ICU stay
Hemameba level
During the first 6 days of ICU stay
C-reaction protein
Time Frame: During the first 6 days of ICU stay
Indicators of infection
During the first 6 days of ICU stay

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Investigators

  • Principal Investigator: huiying Fuhuiying, colleague

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 6, 2022

Primary Completion (Actual)

October 10, 2022

Study Completion (Actual)

November 6, 2022

Study Registration Dates

First Submitted

December 4, 2022

First Submitted That Met QC Criteria

February 13, 2023

First Posted (Actual)

February 14, 2023

Study Record Updates

Last Update Posted (Actual)

May 30, 2023

Last Update Submitted That Met QC Criteria

May 26, 2023

Last Verified

September 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SYSKY-2022-469-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis Bacterial

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe